Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Koch, Alexander ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE RECEPTOR;

BACTEREMIA; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; LUNG INJURY; LUNG LAVAGE; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ARTIFICIAL VENTILATION; BLOOD; BURN; FEMALE; LUNG BURN; MALE;

BURNS; FEMALE; HUMANS; MALE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RESPIRATION, ARTIFICIAL; SMOKE INHALATION INJURY;

EID: 83755220561     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10577     Document Type: Note

References (13)

1. Backes Y, van der Sluijs KF, Tuip de Boer AM, Hofstra JJ, Vlaar APJ, Determann RM, Knape P, Mackie DP, Schultz MJ. suPAR levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort-study. Crit Care 2011, 15:R270. 10.1186/cc10550, 22085408.
2. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 2002, 3:932-943. 10.1038/nrm977, 12461559.
3. Eugen-Olsen J. suPAR - a future risk marker. J Intern Med 2011, 270:29-31. 10.1111/j.1365-2796.2011.02372.x, 21366732.
4. Rabna P, Andersen A, Wejse C, Oliveira I, Francisco Gomes V, Bonde Haaland M, Aaby P, Eugen-Olsen J. Urine suPAR levels compared with plasma suPAR levels as predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study. Inflammation 2010, 33:374-380. 10.1007/s10753-010-9195-2, 20229356.
5. Tzanakaki G, Paparoupa M, Kyprianou M, Barbouni A, Eugen-Olsen J, Kourea-Kremastinou J. Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome. Eur J Clin Microbiol Infect Dis 2011,
6. Koch A, Voigt S, Kruschinski C, Sanson E, Duckers H, Horn A, Yagmur E, Zimmermann H, Trautwein C, Tacke F. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011, 15:R63. 10.1186/cc10037, 3221996, 21324198.
7. Savva A, Raftogiannis M, Baziaka F, Routsi C, Antonopoulou A, Koutoukas P, Tsaganos T, Kotanidou A, Apostolidou E, Giamarellos-Bourboulis EJ, Dimopoulos G. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis. J Infect 2011, 63:344-350. 10.1016/j.jinf.2011.07.016, 21839112.
8. Yilmaz G, Koksal I, Karahan SC, Mentese A. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011, 44:1227-1230. 10.1016/j.clinbiochem.2011.07.006, 21816136.
9. Huttunen R, Syrjanen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011, 270:32-40. 10.1111/j.1365-2796.2011.02363.x, 21332843.
10. Eugen-Olsen J, Andersen O, Linneberg A, Ladelund S, Hansen TW, Langkilde A, Petersen J, Pielak T, Møller LN, Jeppesen J, Lyngbaek S, Fenger M, Olsen MH, Hildebrandt PR, Borch-Johnsen K, Jørgensen T, Haugaard SB. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010, 268:296-308. 10.1111/j.1365-2796.2010.02252.x, 20561148.
11. Langkilde A, Hansen TW, Ladelund S, Linneberg A, Andersen O, Haugaard SB, Jeppesen J, Eugen-Olsen J. Increased plasma soluble uPAR level is a risk marker of respiratory cancer in initially cancer-free individuals. Cancer Epidemiol Biomarkers Prev 2011, 20:609-618. 10.1158/1055-9965.EPI-10-1009, 21239684.
12. Zimmermann HW, Koch A, Seidler S, Trautwein C, Tacke F. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and etiology of cirrhosis and predicts prognosis. Liver Int 2011,
13. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011, 17:952-960. 10.1038/nm.2411, 21804539.